Name | RO5263397 |
---|
Description | RO5263397 is a potent, selective, and orally available TAAR1 agonist, with EC50s of 17 and 35 nM for human TAAR1 and rat TAAR1, respectively. RO5263397 regulates wakefulness and EEG spectral composition. Antidepressant-like effect[1][2][3]. |
---|---|
Related Catalog | |
In Vivo | RO5263397 (0.1-1.0 mg/kg; p.o.; dosing at the mid-light phase (ZT6)) increased wake time at 0.3 and 1 mg/kg[2]. RO5263397 (0.3 and 1.0 mg/kg; p.o.) decreases NREM time in WT mice. RO5263397 (0.3 and 1.0 mg/kg; p.o.; in OE mice) powerfully increases W time in OE mice for 5-6 h. NREM sleep is suppressed for 4-6 h and REM sleep is almost completely suppressed for 6 h after all doses of RO5263397[3]. Animal Model: Adult 4-5-month-old male WT littermates (C57BL/6 background)[2] Dosage: 0.1, 0.3, 1 mg/kg Administration: p.o.; dosing at the mid-light phase (ZT6) Result: Increased wake time at 0.3 and 1 mg/kg |
References |
Molecular Formula | C10H11FN2O |
---|---|
Molecular Weight | 194.2055432 |